FALLON M KAPATAIS
Allopathic & Osteopathic Physicians|Family Medicine NOVI, MI NPI 1477811925
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MI Novo Nordisk AS All categories
General Payments — all program years on this page
$3,226.46
- Category: General Payments
- Program years: PY2018–2024
- Record count: 124
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,138.93 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,138.93 | 64 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $226.06 | 14 |
| Acerta Pharma LLC | $160.40 | 9 |
| ABBVIE INC. | $132.15 | 8 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $108.96 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $80.78 | 4 |
| Lilly USA, LLC | $60.48 | 4 |
| PFIZER INC. | $58.78 | 3 |
| Amgen Inc. | $57.29 | 3 |
| Merck Sharp & Dohme Corporation | $39.20 | 2 |
| E.R. Squibb & Sons, L.L.C. | $31.41 | 2 |
| MEDICOMP INC | $21.64 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.76 | 1 |
| Daiichi Sankyo Inc. | $19.96 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $19.93 | 1 |
| DEXCOM, INC. | $19.87 | 1 |
| Axsome Therapeutics, Inc. | $18.59 | 1 |
| Seqirus USA Inc | $17.95 | 1 |
| SHIELD THERAPEUTICS INC | $15.22 | 1 |
| Amneal Pharmaceuticals LLC | $15.08 | 1 |
| GlaxoSmithKline, LLC. | $14.42 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.